Physician profile
Itay Wiser
NPI 1992225247
$12,654.12
in general payments reported to CMS, 2019-2025
17 companies · $7,333 in 2025
The $7,333 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.45 · 2020: $35.37 · 2021: $2,181 · 2022: $982 · 2023: $722 · 2024: $1,351 · 2025: $7,333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,578 · Travel and Lodging: $3,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,578.05 |
| Travel and Lodging | $3,827.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $4,102.49 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Axogen | $3,663.86 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Stryker Corporation | $1,487.03 | 2021-2024 | Spy-Phi System |
| Sientra, INC. | $911.61 | 2021-2022 | |
| Access Pro Medical, LLC | $831.66 | 2025 | Matriderm |
| Integra Lifesciences Corporation | $470.50 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Motiva USA, LLC | $312.04 | 2024-2025 | |
| Merz North America, INC. | $261.58 | 2020-2024 | |
| Galderma Laboratories, L.P. | $138.89 | 2019-2025 | |
| Allergan, INC. | $136.79 | 2021-2022 | |
| Mentor Worldwide LLC | $118.31 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Baxter Healthcare | $61.27 | 2021-2022 | |
| Sanara Medtech INC. | $49.80 | 2024 | Celleraterx |
| Abbvie INC. | $39.42 | 2023-2024 | Alloderm |
| Davol INC. | $32.80 | 2020-2025 | Phasix Mesh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $19.37 | 2021 | |
| Kerecis Limited | $16.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itay Wiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.